PeptideGLP-1GLP-1 Agonist

Liraglutide

GLP-1 agonist

Typical dose

0.6–3.0 mg DAILY

once DAILY (not weekly) · SubQ

Half-life

~13 hours

What is Liraglutide?

Older daily GLP-1 agonist (shorter half-life than weekly agents).

How Liraglutide works

GLP-1 receptor agonist — reduces appetite, slows gastric emptying, and stimulates glucose-dependent insulin release. Daily injection (shorter-acting than weekly agents).

Benefits & uses

Weight loss
Appetite reduction
Blood-sugar control
Cardiovascular benefit (established in T2DM)

Common uses: Fat loss / obesity, type 2 diabetes.

Liraglutide dosage

Typical dose: Typical: start 0.6 mg/day SubQ, titrate weekly (0.6→1.2→1.8→2.4→3.0 mg/day). Once DAILY, not weekly.

Liraglutide half-life

~13 hours (daily dosing)

Liraglutide side effects

Nausea
Vomiting
Diarrhea
Constipation
Headache
Injection-site reactions

Warnings & monitoring

Daily dosing; titrate slowly
Class risks: pancreatitis, gallbladder disease
Boxed warning: medullary thyroid carcinoma / MEN2 — contraindicated with that history
Not for pregnancy

Preparation & storage

Preparation: Usually pre-filled. If mixing a 5 mg vial with 1 mL bac water → 5 mg/mL, a 0.6 mg dose = 0.12 mL = 12 units. Titrate weekly.
Reconstitution: Usually supplied pre-filled. If lyophilized: reconstitute a 5 mg vial with 1 mL BAC water → 5 mg/mL. A 0.6 mg dose = 0.12 mL = 12 units on a U-100 syringe.

Track Liraglutide in Protokol.

Log doses, model half-lives, check interactions, and line it all up against your bloodwork. Free on iPhone and Android.